Company Overview
- Website
- dana-farber.org/research/departments-centers-and-labs/integrative-research-centers/center-for-patien
- Employees
- 3
- Industry
- Scientific Research
Financials & Stats
Revenue
$3B
Recent News & Media
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
- Feb 19, 2025
- science.org
A heterogeneous pharmaco-transcriptomic landscape induced by targeting a single oncogenic kinase
- Nov 19, 2024
- pmc.ncbi.nlm.nih.gov
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma
- Oct 25, 2024
- pmc.ncbi.nlm.nih.gov
ALK amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma
- Oct 25, 2024
- pmc.ncbi.nlm.nih.gov
Personalized Vascularized Models of Breast Cancer Desmoplasia Reveal Biomechanical Determinants of Drug Delivery to the Tumor
- Jul 23, 2024
- advanced.onlinelibrary.wiley.com
Classifying cell cycle states and a quiescent-like G0 state using single-cell transcriptomics
- Apr 20, 2024
- pmc.ncbi.nlm.nih.gov
DanaFarber Cancer Institute Center for Patient Derived Models Industry Tags
Companies Similar to DanaFarber Cancer Institute Center for Patient Derived Models
Analyze industry trends and opportunities by examining competitors and companies comparable to DanaFarber Cancer Institute Center for Patient Derived Models, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 9 | Rochester, NY | 2009 | |
| 3M | 7 | Phoenix, AZ | 2020 | |
| 3M | 5 | Chicago, IL | 2009 | |
| 3M | 9 | Schaumburg, IL | ||
| 3M | 12 | New York, NY | 2017 |